Eris Lifesciences Ltd.

Financial

	Eris Lifesciences	Torrent Pharma	Astrazeneca Pharma I
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	8.7 %	11.1 %	18.6 %
R&D as a % of Total Sales	0.0	5.0 %	0.0
Financials
5 yr Average ROE	21.87 %	17.02 %	17.46 %
5yr average Equity Multiplier	1.23	2.5	1.97
5yr Average Asset Turnover Ratio	0.65	0.61	0.99
5yr Avg Net Profit Margin	27.87 %	11.26 %	9.04 %
Price to Book	5.03	13.32	20.39
P/E	31.39	59.81	95.86
5yr Avg Cash Conversion Cycle	-52.94 Days	-151.22 Days	-120.04 Days
Inventory Days	26.19 Days	54.43 Days	63.93 Days
Days Receivable	46.91 Days	39.91 Days	35.03 Days
Days Payable	168.01 Days	337.02 Days	229.92 Days
5yr Average Interest Coverage Ratio	96.59	4.68	104.17
5yr Avg ROCE	24.86 %	21.27 %	23.44 %
5yr Avg Operating Profit Margin	36.16 %	29.61 %	15.59 %
5 yr average Debt to Equity	0.11	0.97	0.0
5yr CAGR Net Profit	5.62 %	23.34 %	12.77 %
5yr Average Return on Assets	18.27 %	6.93 %	8.84 %
Shareholdings
Promoter Holding	54.9 %	71.25 %	75.0 %
Share Pledged by Promoters	18.51 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.77 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	5.69 %	-2.01 %	2.92 %

Business

	Eris Lifesciences	Torrent Pharma	Astrazeneca Pharma I
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 US Formulations 0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0 Clinical trials 0 Pharmaceutical products 0	Product Wise Break-Up US Formulations 20.71 Domestic Formulations 42.15 Clinical trials 0 Germany 13.15 Pharmaceutical 0 Pharmaceutical products 0 Brazil 8.98 Contract Manufacturing 6.15 Others 8.86	Product Wise Break-Up US Formulations 0 Domestic formulations 0 Clinical Trial 6.1 Germany/Europe 0 Pharmaceutical 0 Pharmaceutical 93.9 Brazil/Latam 0 Contract Manf. 0
Entity Wise Breakup	Entity Wise Breakup Eris Standalone 95.21 Aprica (BGx) 4.68 Eris M J (Insulin) 0.1 EHPL (TGx) 0 Oaknet (BGx) 0 Others 0.01	-	-
EBITDA - Entity Wise	EBITDA - Entity Wise Eris M J (Insulin) 0 EHPL (TGx) 0 Aprica (BGx) 0 Oaknet (BGx) 0 Eris (Standalone) 0 Others 100	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 29.0 Cardiac Science 21.0 Vitamins / Minerals / Nutrients 16.0 Central Nervous System (CNS) 7.0 Gynecology 5.0 Pain/Analhesics 0 Gastro Intestinal 0 Others 22.0	-	-
Location Wise Break-Up	Location Wise Break-Up South India 39.0 West India 29.0 East India 16.0 North India 16.0 India 0 Germany 0 USA 0 Brazil 0 Rest of the World 0	Location Wise Break-Up Germany 9.88 Brazil 11.42 East India 0 India 51.79 Rest of the World 0 USA 10.03 West India 0 North India 0 South India 0 Others 16.88	Location Wise Break-Up Germany 0 Brazil 0 East India 0 India 93.61 Rest of the World 6.39 USA 0 West India 0 North India 0 South India 0
Acute vs Chronic	Acute vs Chronic Chronic + Sub Chronic Therapies 86.0 Acute 14.0 Sub - chronic 0 Chronic 0 Acute 0	Acute vs Chronic Sub - chronic 0 Chronic + Sub Chronic Therapies 0 Acute 25.0 Chronic 75.0	-

Eris Lifesciences Ltd.

SIGN UP FOR FREE